Italia markets closed

HRMY Jul 2024 35.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,00000,0000 (0,00%)
In data: 11:24AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,0000
Aperto1,0000
Denaro0,0000
Domanda1,1000
Prezzo d'esercizio35,00
Scadenza2024-07-19
Min-Max giorno1,0000 - 1,0000
Contratto - Min-MaxN/D
Volume1
Open Interest154
  • GlobeNewswire

    Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates

    WAKIX® (pitolisant) Net Revenue Increased ~25% Year-over-Year to $134.2 Million for Second Quarter 2023 Average Number of Patients on WAKIX Increased by ~350 Sequentially to ~5,450 for Second Quarter 2023 Exited Second Quarter 2023 With ~5,600 Patients on WAKIX Completed Enrollment in Phase 3 Idiopathic Hypersomnia (IH) INTUNE Study; On-track for Topline Data in Fourth Quarter 2023 Plans to Initiate Prader-Willi Syndrome (PWS) Phase 3 Study in Fourth Quarter 2023 Board of Directors Authorized $1